R. Coleman Lindsley, MD, PhD, Dana-Farber Cancer Institute (IMAGE)

Dana-Farber Cancer Institute

R. Coleman Lindsley, MD, PhD, Dana-Farber Cancer Institute

Caption

Dr. R. Coleman Lindsley led a study showing a single blood test and basic information about a patient's medical status can indicate which patients with myelodysplastic syndrome (MDS) are likely to benefit from a stem cell transplant.

Credit

Dana-Farber Cancer Institute

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.